388 results match your criteria: "Manchester Centre for Clinical Neurosciences[Affiliation]"
J Neurol
December 2024
Department of Neurology, Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, Salford, M6 8HD, UK.
Neurology
December 2024
From the Department of Neurology (S.B.), Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust; Department of Neuroradiology (R.S.), Walton Centre NHS Foundation Trust, Liverpool; North West Genomic Laboratory Hub (Liverpool) (A.S.), Manchester Centre for Genomic Medicine, Liverpool Women's Hospital; MRC Human Genetics Unit (Y.J.C.), Institute of Genetics and Cancer, University of Edinburgh, United Kingdom; Laboratory of Neurogenetics and Neuroinflammation (Y.J.C.), Imagine Institute, INSERM UMR1163, Paris, France; Department of Neurology (C.K.), Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, Salford; and Division of Neuroscience (C.K.), Manchester Academic Health Science Centre, University of Manchester, United Kingdom.
Brain Commun
November 2024
Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK.
Asian J Neurosurg
December 2024
Neurosurgical Oncology Services, Department of Surgical oncology, Tata Memorial Centre, Mumbai, India.
Technology and neurosurgery have gone hand in hand since a long time. Technological development of robotics in neurosurgery over the last couple of decades has been rapid, yet it still has a long way to go before it becomes a "routine" element of the standard neurosurgical procedure. Apart from the obvious advantages they have over humans, that is, precision, consistency, endurance, and reproducibility, robots also provide additional freedom of movement beyond what is anatomically feasible for humans.
View Article and Find Full Text PDFMol Imaging Biol
December 2024
Faculty of Biology, Medicine and Health, School of Health Sciences, Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, M13 9PL, UK.
Purpose: Protein synthesis is essential to maintain integrity and function of the human brain, and protein synthesis is associated specifically with the formation of long-term memory. Experimental and clinical observations indicate that this process is disturbed in Alzheimer's dementia and other neurodegenerative diseases. In-vivo investigation with positron emission tomography (PET) using [C]leucine provides a unique possibility to measure regional cerebral protein synthesis (rCPS) rates in human brain and to determine whether it is altered in Alzheimer's disease (AD), and thus may provide a target for future therapeutic interventions.
View Article and Find Full Text PDFBr J Neurosurg
November 2024
Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Background: Angiogenesis and nascent blood vessel formation is thought to be important in cerebral arteriovenous malformation (cAVM) development and maintenance, of which little is known. Digital subtraction angiogram (DSA) features of angiogenesis in cAVMs are poorly described and the aim of this study was to describe the frequency of angiogenesis in patients who had a DSA showing a cAVM. We also sought to evaluate the intra- and inter-observer agreement of a diagnosis of angiogenesis and explore which angioarchitectural features were associated with angiogenesis.
View Article and Find Full Text PDFHum Brain Mapp
November 2024
Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
J Med Genet
November 2024
Department of Medical Oncology, The Christie Hospital, Manchester, UK.
NeuroSci
June 2024
Centre for Neurological Rare Diseases (CMNR) of LIRH Foundation, 00161 Rome, Italy; (B.D.); (M.S.); (M.C.); (F.S.).
People with Huntington's disease (HD) often experience psychological difficulties linked with disease progression and the adjustment to living with a chronic condition, which are also frequently shared by their informal caregivers (e.g., partners).
View Article and Find Full Text PDFMult Scler
November 2024
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Background: The MSIS-29 measures the physical and psychological impact of MS.
Objective: The associations between MSIS-29 domains and demographic/clinical aspects were examined and trajectories analysed over time.
Methods: Data were collected in the Trajectories of Outcome in Neurological Conditions study for a diverse population of people with MS, with follow-up for up to 5 years.
BJPsych Bull
October 2024
Department of Clinical Neuropsychology, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.
Over the past 50 years, mental health services have evolved significantly, influenced by shifts in theoretical and practical approaches to mental disorders. Key among these changes are the biopsychosocial and recovery models, which highlight resilience and quality of life in treatment. However, traditional psychiatry has often struggled to embrace these changes because of reductionist perspectives that overlook psychosocial factors, resulting in fragmented care and reduced accessibility.
View Article and Find Full Text PDFLancet Neurol
November 2024
Department of Neurology, Manchester Centre for Clinical Neurosciences, Salford, UK.
J Neurol
December 2024
Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Northern Care AllianceNHS Foundation Trust, Salford, UK.
J Cereb Blood Flow Metab
October 2024
Geoffrey Jefferson Brain Research Centre, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Neuroinflammation is a promising therapeutic target in intracerebral hemorrhage (ICH), characterized in the brain by microglial activation and blood-brain barrier (BBB) breakdown. In this study, 36 acute, spontaneous, supratentorial ICH patients underwent dynamic contrast-enhanced MRI to measure BBB permeability () 1-3 days post-onset and 16 returned for [C]()-PK11195 PET to quantify microglial activation (), 2-7 days post-onset. We first tested if these markers were increased and co-localized in the perihematomal brain and found that perihematomal and were increased vs.
View Article and Find Full Text PDFWorld Neurosurg
November 2024
Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Manchester, United Kingdom.
Clin Med (Lond)
September 2024
Infection Neuroscience Laboratory, Institute of Infection, Veterinary and Ecological Science, University of Liverpool, NIHR HPRU for Emerging and Zoonotic Infection, Liverpool, UK.
Reproducible and standardised neurological assessment scales are important in quantifying research outcomes. These scales are often performed by non-neurologists and/or non-clinicians and must be robust, quantifiable, reproducible and comparable to a neurologist's assessment. COVID-CNS is a multi-centre study which utilised the Neurological Impairment Scale (NIS) as a core assessment tool in studying neurological outcomes following COVID-19 infection.
View Article and Find Full Text PDFBr J Neurosurg
August 2024
Emergency Department, Salford Care Organisation, Northern Care Alliance, Salford, UK.
Mov Disord Clin Pract
October 2024
Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, UK.
Background: Severe dysphagia poses a significant challenge for clinicians regarding feeding tube choices, practices, and timing due to a lack of evidence-based guidance.
Objectives: To assess national clinical practices and opinions on gastrostomy use in patients with atypical parkinsonian syndromes (APS) across the UK.
Methods: Online survey was administered to clinicians and allied health professionals regarding availability of services, current use, perceived advantages, and problems associated with gastrostomy insertion.
Semin Arthritis Rheum
October 2024
Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Theme Women's Health and Health Professionals, Medical Unit Allied Health Professionals, Karolinska University Hospital, Stockholm, Sweden.
Rheumatol Int
October 2024
Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
BMJ Support Palliat Care
August 2024
Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
Objectives: People with multiple system atrophy (MSA) and their carers may have many concerns about their disease and the future. This survey of people with MSA and their carers aimed to increase understanding of end-of-life care and palliative care for this group.
Methods: A survey was undertaken by the MSA Trust of people living with MSA and carers of those with the condition between August and October 2022.
Surg Neurol Int
July 2024
Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford, United Kingdom.
Background: In recent times, clinical negligence claims against National Health Service hospitals have doubled, with 8% of claims being made due to "failure to warn/informed consent." This study aimed to assess the current compliance of the neurosurgical division within a large tertiary neuroscience center with the national legal framework and professional guidelines around the issue of surgical consent and to develop strategies to improve the consent process.
Methods: Electronic patient records (EPR) were accessed to collect demographic data and information regarding the surgical procedures.
Diffuse neurofibroma of the head and neck are rare tumours which have unique clinical and radiological findings. Presurgical diagnosis is important as these lesions are usually highly vascular and pre-operative embolisation can reduce the risk of intra-operative haemorrhage. In this article we describe four cases; two which underwent pre-operative embolisation, which should aid the reader in successfully diagnosing this entity before biopsy/surgery.
View Article and Find Full Text PDFPract Neurol
July 2024
Neurology, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Salford, UK.
Brain
December 2024
The John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute, Newcastle Upon Tyne NHS Trust, Newcastle Upon Tyne, NE13BZ, UK.